[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fh_yUNT2Dkknj-4_apCzFergbX4iH-gXEUe9EK55zpwQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":57,"rows":64},"Aalborg University Hospital",[4],193,false,41,3,105858,8,163,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"BPPV",4,{"name":18,"count":16},"Recurrent Pregnancy Loss",{"name":20,"count":16},"Colorectal Cancer",{"name":22,"count":16},"Low Back Pain",{"name":24,"count":9},"Benign Paroxysmal Positional Vertigo",{"name":26,"count":9},"Atrial Fibrillation",{"name":28,"count":9},"Habitual Abortion",{"name":30,"count":9},"Pulmonary Embolism",[32,37,42,47,52],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT06686641","Incidence of Macular Edema in a Uveitis Population","2024-10-31","Local and systemical treatment",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05436054","A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy","2025-12-01","Picoprep",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT06790082","The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma","2027-04-30","[68Ga]Ga-FAPI-46 PET\u002FCT",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT07185958","Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy","2028-03-21","Iodine-based contrast agent",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT05913947","Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)","2028-09-01","Lithium",[58,59,60,61,62,63],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[65,90,108,131,149,175,201,219,243,287,313,331,356,380,409,427,453,471,496,522,540,576,603,621,647,672,698,716,743,761,779,803,828,856,874,900,918,945,963,986,1011,1036],{"intervention":41,"totalTrials":66,"cells":67},1,{"EARLY_PHASE1":68,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":88},{"trials":69,"activeCount":70},[],0,{"trials":72,"activeCount":70},[],{"trials":74,"activeCount":70},[],{"trials":76,"activeCount":70},[],{"trials":78,"activeCount":66,"soonestReadout":40},[79],{"nctId":38,"briefTitle":39,"status":80,"phases":81,"primaryCompletion":40,"completion":40,"start":82,"enrollment":83,"conditions":84,"interventions":86},"RECRUITING",[62],"2022-10-01",400,[85],"Colon Disease",[41,87],"Plenvu",{"trials":89,"activeCount":70},[],{"intervention":87,"totalTrials":66,"cells":91},{"EARLY_PHASE1":92,"PHASE1":94,"PHASE2":96,"PHASE3":98,"PHASE4":100,"NA":106},{"trials":93,"activeCount":70},[],{"trials":95,"activeCount":70},[],{"trials":97,"activeCount":70},[],{"trials":99,"activeCount":70},[],{"trials":101,"activeCount":66,"soonestReadout":40},[102],{"nctId":38,"briefTitle":39,"status":80,"phases":103,"primaryCompletion":40,"completion":40,"start":82,"enrollment":83,"conditions":104,"interventions":105},[62],[85],[41,87],{"trials":107,"activeCount":70},[],{"intervention":56,"totalTrials":66,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":129},{"trials":111,"activeCount":70},[],{"trials":113,"activeCount":70},[],{"trials":115,"activeCount":70},[],{"trials":117,"activeCount":70},[],{"trials":119,"activeCount":66,"soonestReadout":55},[120],{"nctId":53,"briefTitle":54,"status":80,"phases":121,"primaryCompletion":55,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},[62],"2028-09-02","2022-12-13",122,[126],"Depression, Bipolar",[56,128],"Cariprazine",{"trials":130,"activeCount":70},[],{"intervention":128,"totalTrials":66,"cells":132},{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":147},{"trials":134,"activeCount":70},[],{"trials":136,"activeCount":70},[],{"trials":138,"activeCount":70},[],{"trials":140,"activeCount":70},[],{"trials":142,"activeCount":66,"soonestReadout":55},[143],{"nctId":53,"briefTitle":54,"status":80,"phases":144,"primaryCompletion":55,"completion":122,"start":123,"enrollment":124,"conditions":145,"interventions":146},[62],[126],[56,128],{"trials":148,"activeCount":70},[],{"intervention":46,"totalTrials":66,"cells":150},{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":169,"PHASE4":171,"NA":173},{"trials":152,"activeCount":70},[],{"trials":154,"activeCount":70},[],{"trials":156,"activeCount":66,"soonestReadout":45},[157],{"nctId":43,"briefTitle":44,"status":80,"phases":158,"primaryCompletion":45,"completion":159,"start":160,"enrollment":161,"conditions":162,"interventions":168},[60],"2037-04-30","2025-01-29",70,[163,164,165,166,167],"Pleural Mesothelioma","Pleural Diseases","Cancer","FAPI","Fibroblast Activation Protein Inhibitor",[46],{"trials":170,"activeCount":70},[],{"trials":172,"activeCount":70},[],{"trials":174,"activeCount":70},[],{"intervention":51,"totalTrials":66,"cells":176},{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":185,"NA":187},{"trials":178,"activeCount":70},[],{"trials":180,"activeCount":70},[],{"trials":182,"activeCount":70},[],{"trials":184,"activeCount":70},[],{"trials":186,"activeCount":70},[],{"trials":188,"activeCount":66,"soonestReadout":50},[189],{"nctId":48,"briefTitle":49,"status":190,"phases":191,"primaryCompletion":50,"completion":50,"start":192,"enrollment":193,"conditions":194,"interventions":199},"NOT_YET_RECRUITING",[],"2025-09-22",80,[195,196,197,198],"Brain Metastases","Bone Metastases","Head and Neck Cancer","Lung Cancer",[51,200],"Gadolinium-based contrast agent",{"intervention":200,"totalTrials":66,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":213},{"trials":204,"activeCount":70},[],{"trials":206,"activeCount":70},[],{"trials":208,"activeCount":70},[],{"trials":210,"activeCount":70},[],{"trials":212,"activeCount":70},[],{"trials":214,"activeCount":66,"soonestReadout":50},[215],{"nctId":48,"briefTitle":49,"status":190,"phases":216,"primaryCompletion":50,"completion":50,"start":192,"enrollment":193,"conditions":217,"interventions":218},[],[195,196,197,198],[51,200],{"intervention":36,"totalTrials":66,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":231},{"trials":222,"activeCount":70},[],{"trials":224,"activeCount":70},[],{"trials":226,"activeCount":70},[],{"trials":228,"activeCount":70},[],{"trials":230,"activeCount":70},[],{"trials":232,"activeCount":66,"soonestReadout":35},[233],{"nctId":33,"briefTitle":34,"status":234,"phases":235,"primaryCompletion":35,"completion":236,"start":237,"enrollment":238,"conditions":239,"interventions":242},"ACTIVE_NOT_RECRUITING",[],"2025-02-01","2024-05-01",1550,[240,241],"Macular Edema","Non-infectious Uveitis",[36],{"intervention":244,"totalTrials":245,"cells":246},"Oxygen",2,{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":255,"NA":285},{"trials":248,"activeCount":70},[],{"trials":250,"activeCount":70},[],{"trials":252,"activeCount":70},[],{"trials":254,"activeCount":70},[],{"trials":256,"activeCount":70},[257,270],{"nctId":258,"briefTitle":259,"status":260,"phases":261,"primaryCompletion":262,"completion":263,"start":264,"enrollment":265,"conditions":266,"interventions":269},"NCT03174002","Handling Oxygenation Targets in the Intensive Care Unit","COMPLETED",[62],"2020-11-03","2021-08-03","2017-06-19",2928,[267,268],"Hypoxemic Respiratory Failure","Oxygen Toxicity",[244,244],{"nctId":271,"briefTitle":272,"status":273,"phases":274,"primaryCompletion":275,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":284},"NCT04133740","Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study","UNKNOWN",[62],"2019-07-15","2020-07-31","2018-10-01",50,[280,281,282,283,268],"Hyperoxia","Cardiac Surgery","Cardiopulmonary Bypass","Acute Lung Injury",[244],{"trials":286,"activeCount":70},[],{"intervention":288,"totalTrials":66,"cells":289},"Low oxygenation target",{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":298,"NA":311},{"trials":291,"activeCount":70},[],{"trials":293,"activeCount":70},[],{"trials":295,"activeCount":70},[],{"trials":297,"activeCount":70},[],{"trials":299,"activeCount":70},[300],{"nctId":301,"briefTitle":302,"status":260,"phases":303,"primaryCompletion":304,"completion":305,"start":306,"enrollment":307,"conditions":308,"interventions":309},"NCT04425031","Handling Oxygenation Targets in COVID-19",[62],"2023-03-08","2024-03-08","2020-08-25",726,[267,268],[288,310],"High oxygenation target",{"trials":312,"activeCount":70},[],{"intervention":310,"totalTrials":66,"cells":314},{"EARLY_PHASE1":315,"PHASE1":317,"PHASE2":319,"PHASE3":321,"PHASE4":323,"NA":329},{"trials":316,"activeCount":70},[],{"trials":318,"activeCount":70},[],{"trials":320,"activeCount":70},[],{"trials":322,"activeCount":70},[],{"trials":324,"activeCount":70},[325],{"nctId":301,"briefTitle":302,"status":260,"phases":326,"primaryCompletion":304,"completion":305,"start":306,"enrollment":307,"conditions":327,"interventions":328},[62],[267,268],[288,310],{"trials":330,"activeCount":70},[],{"intervention":332,"totalTrials":66,"cells":333},"Aspirin",{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":354},{"trials":335,"activeCount":70},[],{"trials":337,"activeCount":70},[],{"trials":339,"activeCount":70},[],{"trials":341,"activeCount":70},[],{"trials":343,"activeCount":70},[344],{"nctId":345,"briefTitle":346,"status":260,"phases":347,"primaryCompletion":348,"completion":348,"start":349,"enrollment":350,"conditions":351,"interventions":353},"NCT00262561","Resistance to Aspirin and\u002For Clopidogrel Among Patients With PAD.",[62],"2008-01","2006-01",263,[352],"Intermittent Claudication",[332],{"trials":355,"activeCount":70},[],{"intervention":357,"totalTrials":66,"cells":358},"Psyllium husks",{"EARLY_PHASE1":359,"PHASE1":361,"PHASE2":363,"PHASE3":365,"PHASE4":367,"NA":378},{"trials":360,"activeCount":70},[],{"trials":362,"activeCount":70},[],{"trials":364,"activeCount":70},[],{"trials":366,"activeCount":70},[],{"trials":368,"activeCount":70},[369],{"nctId":370,"briefTitle":371,"status":260,"phases":372,"primaryCompletion":373,"completion":373,"start":374,"enrollment":8,"conditions":375,"interventions":377},"NCT01251991","Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia",[62],"2012-01","2011-01",[376],"Hypercholesterolemia",[357],{"trials":379,"activeCount":70},[],{"intervention":381,"totalTrials":66,"cells":382},"Ibuprofene",{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":391,"NA":407},{"trials":384,"activeCount":70},[],{"trials":386,"activeCount":70},[],{"trials":388,"activeCount":70},[],{"trials":390,"activeCount":70},[],{"trials":392,"activeCount":70},[393],{"nctId":394,"briefTitle":395,"status":260,"phases":396,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":401,"interventions":405},"NCT02479165","Pain Management After Cardiac Surgery - Opioids or NSAID",[62],"2010-09","2013-09","2009-05",182,[402,403,404],"Postoperative Pain","Renal Insufficiency","Myocardial Infarction",[381,406],"Oxycodone",{"trials":408,"activeCount":70},[],{"intervention":406,"totalTrials":66,"cells":410},{"EARLY_PHASE1":411,"PHASE1":413,"PHASE2":415,"PHASE3":417,"PHASE4":419,"NA":425},{"trials":412,"activeCount":70},[],{"trials":414,"activeCount":70},[],{"trials":416,"activeCount":70},[],{"trials":418,"activeCount":70},[],{"trials":420,"activeCount":70},[421],{"nctId":394,"briefTitle":395,"status":260,"phases":422,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":423,"interventions":424},[62],[402,403,404],[381,406],{"trials":426,"activeCount":70},[],{"intervention":428,"totalTrials":66,"cells":429},"unfractionated heparin",{"EARLY_PHASE1":430,"PHASE1":432,"PHASE2":434,"PHASE3":436,"PHASE4":449,"NA":451},{"trials":431,"activeCount":70},[],{"trials":433,"activeCount":70},[],{"trials":435,"activeCount":70},[],{"trials":437,"activeCount":70},[438],{"nctId":439,"briefTitle":440,"status":260,"phases":441,"primaryCompletion":442,"completion":442,"start":443,"enrollment":444,"conditions":445,"interventions":447},"NCT00628576","Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities",[61],"2004-06","1993-10",99,[446],"Deep Venous Thrombosis",[428,448],"Tinzaparin",{"trials":450,"activeCount":70},[],{"trials":452,"activeCount":70},[],{"intervention":448,"totalTrials":66,"cells":454},{"EARLY_PHASE1":455,"PHASE1":457,"PHASE2":459,"PHASE3":461,"PHASE4":467,"NA":469},{"trials":456,"activeCount":70},[],{"trials":458,"activeCount":70},[],{"trials":460,"activeCount":70},[],{"trials":462,"activeCount":70},[463],{"nctId":439,"briefTitle":440,"status":260,"phases":464,"primaryCompletion":442,"completion":442,"start":443,"enrollment":444,"conditions":465,"interventions":466},[61],[446],[428,448],{"trials":468,"activeCount":70},[],{"trials":470,"activeCount":70},[],{"intervention":472,"totalTrials":66,"cells":473},"Pregabalin",{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":492,"NA":494},{"trials":475,"activeCount":70},[],{"trials":477,"activeCount":70},[],{"trials":479,"activeCount":70},[],{"trials":481,"activeCount":70},[482],{"nctId":483,"briefTitle":484,"status":260,"phases":485,"primaryCompletion":486,"completion":486,"start":487,"enrollment":488,"conditions":489,"interventions":491},"NCT00755573","Pain and Chronic Pancreatitis - Clinical End Experimental Studies",[60,61],"2010-05","2008-10",64,[490],"Chronic Pancreatitis",[472],{"trials":493,"activeCount":70},[],{"trials":495,"activeCount":70},[],{"intervention":497,"totalTrials":66,"cells":498},"Twinrix",{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":503,"PHASE3":505,"PHASE4":518,"NA":520},{"trials":500,"activeCount":70},[],{"trials":502,"activeCount":70},[],{"trials":504,"activeCount":70},[],{"trials":506,"activeCount":70},[507],{"nctId":508,"briefTitle":509,"status":273,"phases":510,"start":511,"enrollment":193,"conditions":512,"interventions":516},"NCT00451984","Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2",[61],"2007-03",[513,514,515],"HIV Infections","Hepatitis A","Hepatitis B",[497,517],"interleukin-2",{"trials":519,"activeCount":70},[],{"trials":521,"activeCount":70},[],{"intervention":517,"totalTrials":66,"cells":523},{"EARLY_PHASE1":524,"PHASE1":526,"PHASE2":528,"PHASE3":530,"PHASE4":536,"NA":538},{"trials":525,"activeCount":70},[],{"trials":527,"activeCount":70},[],{"trials":529,"activeCount":70},[],{"trials":531,"activeCount":70},[532],{"nctId":508,"briefTitle":509,"status":273,"phases":533,"start":511,"enrollment":193,"conditions":534,"interventions":535},[61],[513,514,515],[497,517],{"trials":537,"activeCount":70},[],{"trials":539,"activeCount":70},[],{"intervention":541,"totalTrials":245,"cells":542},"68Ga-FAPi-46",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":570,"PHASE4":572,"NA":574},{"trials":544,"activeCount":70},[],{"trials":546,"activeCount":70},[],{"trials":548,"activeCount":70},[549,560],{"nctId":550,"briefTitle":551,"status":260,"phases":552,"primaryCompletion":553,"completion":553,"start":554,"enrollment":555,"conditions":556,"interventions":559},"NCT05898854","[68Ga]Ga-FAPI PET\u002FCT in Gastric and Gastroesophageal Junctional Cancer",[60],"2025-12-18","2024-02-15",20,[557,558,165],"Gastric Cancer","Gastro Esophageal Junctional Cancer",[541],{"nctId":561,"briefTitle":562,"status":563,"phases":564,"primaryCompletion":565,"completion":565,"start":566,"enrollment":555,"conditions":567,"interventions":569},"NCT05903807","[68Ga]Ga-FAPI-46 PET\u002FCT in Ovarian Cancer","TERMINATED",[60],"2026-05-08","2023-11-17",[568],"Ovarian Cancer",[541],{"trials":571,"activeCount":70},[],{"trials":573,"activeCount":70},[],{"trials":575,"activeCount":70},[],{"intervention":577,"totalTrials":66,"cells":578},"r-metHuSCF and Filgrastim",{"EARLY_PHASE1":579,"PHASE1":581,"PHASE2":583,"PHASE3":597,"PHASE4":599,"NA":601},{"trials":580,"activeCount":70},[],{"trials":582,"activeCount":70},[],{"trials":584,"activeCount":70},[585],{"nctId":586,"briefTitle":587,"status":563,"phases":588,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":593,"interventions":595},"NCT01016795","Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma",[60],"2000-11","2009-11","1999-01",32,[594],"Malignant Lymphoma",[577,577,596],"Chemotherapy plus Filgrastim",{"trials":598,"activeCount":70},[],{"trials":600,"activeCount":70},[],{"trials":602,"activeCount":70},[],{"intervention":596,"totalTrials":66,"cells":604},{"EARLY_PHASE1":605,"PHASE1":607,"PHASE2":609,"PHASE3":615,"PHASE4":617,"NA":619},{"trials":606,"activeCount":70},[],{"trials":608,"activeCount":70},[],{"trials":610,"activeCount":70},[611],{"nctId":586,"briefTitle":587,"status":563,"phases":612,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":613,"interventions":614},[60],[594],[577,577,596],{"trials":616,"activeCount":70},[],{"trials":618,"activeCount":70},[],{"trials":620,"activeCount":70},[],{"intervention":622,"totalTrials":66,"cells":623},"Cannabidiol",{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":625,"activeCount":70},[],{"trials":627,"activeCount":70},[],{"trials":629,"activeCount":70},[630],{"nctId":631,"briefTitle":632,"status":260,"phases":633,"primaryCompletion":634,"completion":634,"start":635,"enrollment":636,"conditions":637,"interventions":640},"NCT03693833","CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.",[60],"2021-06-01","2018-11-28",136,[638,639],"Psoriatic Arthritis","Hand Osteoarthritis",[622],{"trials":642,"activeCount":70},[],{"trials":644,"activeCount":70},[],{"trials":646,"activeCount":70},[],{"intervention":648,"totalTrials":66,"cells":649},"lipid emulsion with a high content of n-3 fatty acids",{"EARLY_PHASE1":650,"PHASE1":652,"PHASE2":654,"PHASE3":666,"PHASE4":668,"NA":670},{"trials":651,"activeCount":70},[],{"trials":653,"activeCount":70},[],{"trials":655,"activeCount":70},[656],{"nctId":657,"briefTitle":658,"status":260,"phases":659,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":663,"interventions":665},"NCT00259025","Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients",[60],"2007-07","2006-09",60,[664],"Renal Failure, Chronic",[648],{"trials":667,"activeCount":70},[],{"trials":669,"activeCount":70},[],{"trials":671,"activeCount":70},[],{"intervention":673,"totalTrials":66,"cells":674},"Omegaven",{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":692,"PHASE4":694,"NA":696},{"trials":676,"activeCount":70},[],{"trials":678,"activeCount":70},[],{"trials":680,"activeCount":70},[681],{"nctId":682,"briefTitle":683,"status":260,"phases":684,"primaryCompletion":685,"completion":685,"start":686,"enrollment":11,"conditions":687,"interventions":690},"NCT00534300","Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker",[59,60],"2008-06","2007-10",[688,689],"Ventricular Tachycardia","Sudden Cardiac Death",[673,691],"Isotonic saline",{"trials":693,"activeCount":70},[],{"trials":695,"activeCount":70},[],{"trials":697,"activeCount":70},[],{"intervention":691,"totalTrials":66,"cells":699},{"EARLY_PHASE1":700,"PHASE1":702,"PHASE2":704,"PHASE3":710,"PHASE4":712,"NA":714},{"trials":701,"activeCount":70},[],{"trials":703,"activeCount":70},[],{"trials":705,"activeCount":70},[706],{"nctId":682,"briefTitle":683,"status":260,"phases":707,"primaryCompletion":685,"completion":685,"start":686,"enrollment":11,"conditions":708,"interventions":709},[59,60],[688,689],[673,691],{"trials":711,"activeCount":70},[],{"trials":713,"activeCount":70},[],{"trials":715,"activeCount":70},[],{"intervention":717,"totalTrials":66,"cells":718},"Human Intravenous Immunoglobulins,",{"EARLY_PHASE1":719,"PHASE1":721,"PHASE2":723,"PHASE3":737,"PHASE4":739,"NA":741},{"trials":720,"activeCount":70},[],{"trials":722,"activeCount":70},[],{"trials":724,"activeCount":70},[725],{"nctId":726,"briefTitle":727,"status":260,"phases":728,"primaryCompletion":729,"completion":729,"start":730,"enrollment":193,"conditions":731,"interventions":734},"NCT04701034","Intravenous Immunoglobulin and Prednisolone for RPL After ART.",[60],"2024-04-18","2021-01-28",[28,18,732,733],"Fertility Disorders","Miscarriage",[717,735,736],"Prednisolone","Human Albumin Solution",{"trials":738,"activeCount":70},[],{"trials":740,"activeCount":70},[],{"trials":742,"activeCount":70},[],{"intervention":735,"totalTrials":66,"cells":744},{"EARLY_PHASE1":745,"PHASE1":747,"PHASE2":749,"PHASE3":755,"PHASE4":757,"NA":759},{"trials":746,"activeCount":70},[],{"trials":748,"activeCount":70},[],{"trials":750,"activeCount":70},[751],{"nctId":726,"briefTitle":727,"status":260,"phases":752,"primaryCompletion":729,"completion":729,"start":730,"enrollment":193,"conditions":753,"interventions":754},[60],[28,18,732,733],[717,735,736],{"trials":756,"activeCount":70},[],{"trials":758,"activeCount":70},[],{"trials":760,"activeCount":70},[],{"intervention":736,"totalTrials":66,"cells":762},{"EARLY_PHASE1":763,"PHASE1":765,"PHASE2":767,"PHASE3":773,"PHASE4":775,"NA":777},{"trials":764,"activeCount":70},[],{"trials":766,"activeCount":70},[],{"trials":768,"activeCount":70},[769],{"nctId":726,"briefTitle":727,"status":260,"phases":770,"primaryCompletion":729,"completion":729,"start":730,"enrollment":193,"conditions":771,"interventions":772},[60],[28,18,732,733],[717,735,736],{"trials":774,"activeCount":70},[],{"trials":776,"activeCount":70},[],{"trials":778,"activeCount":70},[],{"intervention":780,"totalTrials":66,"cells":781},"Advanced platelet-rich fibrin in the ekstraction socket",{"EARLY_PHASE1":782,"PHASE1":793,"PHASE2":795,"PHASE3":797,"PHASE4":799,"NA":801},{"trials":783,"activeCount":70},[784],{"nctId":785,"briefTitle":786,"status":273,"phases":787,"primaryCompletion":788,"completion":40,"start":789,"enrollment":193,"conditions":790,"interventions":792},"NCT06377839","Pain After Removal of Mandibular Third Molars With or Without Advanced Platelet-rich Fibrin",[58],"2024-04-17","2024-01-10",[791],"Pain Syndrome",[780],{"trials":794,"activeCount":70},[],{"trials":796,"activeCount":70},[],{"trials":798,"activeCount":70},[],{"trials":800,"activeCount":70},[],{"trials":802,"activeCount":70},[],{"intervention":804,"totalTrials":66,"cells":805},"Whole genome amplification",{"EARLY_PHASE1":806,"PHASE1":808,"PHASE2":810,"PHASE3":812,"PHASE4":814,"NA":816},{"trials":807,"activeCount":70},[],{"trials":809,"activeCount":70},[],{"trials":811,"activeCount":70},[],{"trials":813,"activeCount":70},[],{"trials":815,"activeCount":70},[],{"trials":817,"activeCount":70},[818],{"nctId":819,"briefTitle":820,"status":260,"phases":821,"primaryCompletion":822,"completion":822,"start":823,"enrollment":824,"conditions":825,"interventions":827},"NCT05453474","Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling",[63],"2023-06-27","2021-08-08",48,[826],"Hereditary Diseases",[804],{"intervention":829,"totalTrials":66,"cells":830},"Ropivacaine",{"EARLY_PHASE1":831,"PHASE1":833,"PHASE2":835,"PHASE3":837,"PHASE4":839,"NA":841},{"trials":832,"activeCount":70},[],{"trials":834,"activeCount":70},[],{"trials":836,"activeCount":70},[],{"trials":838,"activeCount":70},[],{"trials":840,"activeCount":70},[],{"trials":842,"activeCount":70},[843],{"nctId":844,"briefTitle":845,"status":563,"phases":846,"primaryCompletion":847,"completion":848,"start":849,"enrollment":193,"conditions":850,"interventions":854},"NCT01760161","Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery",[63],"2015-12","2016-02","2014-04",[851,852,853],"Pain Treatment","Robotic Assisted Laparoscopic Surgery","Bilateral Dual Transversus Abdominis Plane Block",[829,855],"Isotonic potassium chloride",{"intervention":855,"totalTrials":66,"cells":857},{"EARLY_PHASE1":858,"PHASE1":860,"PHASE2":862,"PHASE3":864,"PHASE4":866,"NA":868},{"trials":859,"activeCount":70},[],{"trials":861,"activeCount":70},[],{"trials":863,"activeCount":70},[],{"trials":865,"activeCount":70},[],{"trials":867,"activeCount":70},[],{"trials":869,"activeCount":70},[870],{"nctId":844,"briefTitle":845,"status":563,"phases":871,"primaryCompletion":847,"completion":848,"start":849,"enrollment":193,"conditions":872,"interventions":873},[63],[851,852,853],[829,855],{"intervention":875,"totalTrials":66,"cells":876},"Propofol",{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":885,"NA":887},{"trials":878,"activeCount":70},[],{"trials":880,"activeCount":70},[],{"trials":882,"activeCount":70},[],{"trials":884,"activeCount":70},[],{"trials":886,"activeCount":70},[],{"trials":888,"activeCount":70},[889],{"nctId":890,"briefTitle":891,"status":563,"phases":892,"primaryCompletion":893,"completion":893,"start":894,"enrollment":895,"conditions":896,"interventions":898},"NCT01043952","Use of Bispectral Index (BIS) for Monitoring of Total Intravenous Anaesthesia in Pediatric Patients",[63],"2012-03","2010-01",157,[897],"Anesthesia, General",[875,899],"Remifentanil",{"intervention":899,"totalTrials":66,"cells":901},{"EARLY_PHASE1":902,"PHASE1":904,"PHASE2":906,"PHASE3":908,"PHASE4":910,"NA":912},{"trials":903,"activeCount":70},[],{"trials":905,"activeCount":70},[],{"trials":907,"activeCount":70},[],{"trials":909,"activeCount":70},[],{"trials":911,"activeCount":70},[],{"trials":913,"activeCount":70},[914],{"nctId":890,"briefTitle":891,"status":563,"phases":915,"primaryCompletion":893,"completion":893,"start":894,"enrollment":895,"conditions":916,"interventions":917},[63],[897],[875,899],{"intervention":919,"totalTrials":66,"cells":920},"Ropivacaine bolus in transversus abdominis plane catheter",{"EARLY_PHASE1":921,"PHASE1":923,"PHASE2":925,"PHASE3":927,"PHASE4":929,"NA":931},{"trials":922,"activeCount":70},[],{"trials":924,"activeCount":70},[],{"trials":926,"activeCount":70},[],{"trials":928,"activeCount":70},[],{"trials":930,"activeCount":70},[],{"trials":932,"activeCount":70},[933],{"nctId":934,"briefTitle":935,"status":936,"phases":937,"primaryCompletion":938,"completion":939,"start":940,"enrollment":70,"conditions":941,"interventions":943},"NCT01760174","Comparing the Effect of TAP-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery","WITHDRAWN",[63],"2016-12","2017-02","2016-01",[942],"Pain, Postoperative",[919,944],"Bupivacain-infusion in epidural catheter",{"intervention":944,"totalTrials":66,"cells":946},{"EARLY_PHASE1":947,"PHASE1":949,"PHASE2":951,"PHASE3":953,"PHASE4":955,"NA":957},{"trials":948,"activeCount":70},[],{"trials":950,"activeCount":70},[],{"trials":952,"activeCount":70},[],{"trials":954,"activeCount":70},[],{"trials":956,"activeCount":70},[],{"trials":958,"activeCount":70},[959],{"nctId":934,"briefTitle":935,"status":936,"phases":960,"primaryCompletion":938,"completion":939,"start":940,"enrollment":70,"conditions":961,"interventions":962},[63],[942],[919,944],{"intervention":964,"totalTrials":66,"cells":965},"Bupivacain 2.5 mg\u002Fml with epinephrine bolus in TAP-catheters",{"EARLY_PHASE1":966,"PHASE1":968,"PHASE2":970,"PHASE3":972,"PHASE4":974,"NA":976},{"trials":967,"activeCount":70},[],{"trials":969,"activeCount":70},[],{"trials":971,"activeCount":70},[],{"trials":973,"activeCount":70},[],{"trials":975,"activeCount":70},[],{"trials":977,"activeCount":70},[978],{"nctId":979,"briefTitle":980,"status":260,"phases":981,"primaryCompletion":982,"completion":982,"start":397,"enrollment":983,"conditions":984,"interventions":985},"NCT01395043","Transversus Abdominis Plane Catheter: a Study of Method",[63],"2011-06",15,[402],[964],{"intervention":987,"totalTrials":66,"cells":988},"Liraglutide treatment",{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":999},{"trials":990,"activeCount":70},[],{"trials":992,"activeCount":70},[],{"trials":994,"activeCount":70},[],{"trials":996,"activeCount":70},[],{"trials":998,"activeCount":70},[],{"trials":1000,"activeCount":70},[1001],{"nctId":1002,"briefTitle":1003,"status":260,"phases":1004,"primaryCompletion":939,"completion":939,"start":1005,"enrollment":1006,"conditions":1007,"interventions":1010},"NCT02138045","Treatment of Diabetic Neuropathy With Liraglutide",[63],"2014-05",39,[1008,1009],"Diabetes Mellitus, Type 1","Type 1 Diabetes Mellitus",[987],{"intervention":1012,"totalTrials":66,"cells":1013},"Corticosteroid",{"EARLY_PHASE1":1014,"PHASE1":1016,"PHASE2":1018,"PHASE3":1020,"PHASE4":1022,"NA":1024},{"trials":1015,"activeCount":70},[],{"trials":1017,"activeCount":70},[],{"trials":1019,"activeCount":70},[],{"trials":1021,"activeCount":70},[],{"trials":1023,"activeCount":70},[],{"trials":1025,"activeCount":70},[1026],{"nctId":1027,"briefTitle":1028,"status":260,"phases":1029,"primaryCompletion":1030,"completion":1031,"start":1032,"enrollment":278,"conditions":1033,"interventions":1035},"NCT03821155","Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?",[63],"2021-07-01","2022-01-01","2019-02-01",[1034],"Vestibular Neuritis",[1012],{"intervention":1037,"totalTrials":66,"cells":1038},"Focused shockwave therapy",{"EARLY_PHASE1":1039,"PHASE1":1041,"PHASE2":1043,"PHASE3":1045,"PHASE4":1047,"NA":1049},{"trials":1040,"activeCount":70},[],{"trials":1042,"activeCount":70},[],{"trials":1044,"activeCount":70},[],{"trials":1046,"activeCount":70},[],{"trials":1048,"activeCount":70},[],{"trials":1050,"activeCount":70},[1051],{"nctId":1052,"briefTitle":1053,"status":273,"phases":1054,"primaryCompletion":1055,"completion":1056,"start":635,"enrollment":662,"conditions":1057,"interventions":1059},"NCT04058509","Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Lateral Hip Pain",[63],"2019-12-30","2020-07-30",[1058],"Tendinopathy",[1037]]